Abstract
Stress and anxiety disorders are risk factors for depression and these behaviors are modulated by corticotrophin-releasing factor receptor 1 (CRFR1) and serotonin receptor (5-HT(2)R). However, the potential behavioral and cellular interaction between these two receptors is unclear. We found that pre-administration of corticotrophin-releasing factor (CRF) into the prefrontal cortex of mice enhanced 5-HT(2)R-mediated anxiety behaviors in response to 2,5-dimethoxy-4-iodoamphetamine. In both heterologous cell cultures and mouse cortical neurons, activation of CRFR1 also enhanced 5-HT(2) receptor-mediated inositol phosphate formation. CRFR1-mediated increases in 5-HT(2)R signaling were dependent on receptor internalization and receptor recycling via rapid recycling endosomes, resulting in increased expression of 5-HT(2)R on the cell surface. Sensitization of 5-HT(2)R signaling by CRFR1 required intact PDZ domain-binding motifs at the end of the C-terminal tails of both receptor types. These data suggest a mechanism by which CRF, a peptide known to be released by stress, enhances anxiety-related behavior via sensitization of 5-HT(2)R signaling.
Publication types
-
Research Support, N.I.H., Extramural
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Amphetamines / pharmacology
-
Animals
-
Anxiety / drug therapy
-
Anxiety / metabolism*
-
Anxiety / physiopathology
-
Behavior, Animal / drug effects
-
Behavior, Animal / physiology
-
Biotinylation / methods
-
CRF Receptor, Type 1
-
Cells, Cultured
-
Corticotropin-Releasing Hormone / pharmacology
-
Cyclic AMP / metabolism
-
Disease Models, Animal
-
Dose-Response Relationship, Drug
-
Embryo, Mammalian
-
Fluorobenzenes / pharmacology
-
Hormones / pharmacology
-
Humans
-
Inositol Phosphates / metabolism
-
Ionophores / pharmacology
-
Male
-
Maze Learning / drug effects
-
Maze Learning / physiology
-
Mice
-
Monensin / pharmacology
-
Mutation / genetics
-
Neurons
-
Piperidines / pharmacology
-
Prefrontal Cortex / cytology
-
Rats
-
Reaction Time / drug effects
-
Receptors, Corticotropin-Releasing Hormone / genetics
-
Receptors, Corticotropin-Releasing Hormone / physiology*
-
Receptors, Serotonin, 5-HT2 / genetics
-
Receptors, Serotonin, 5-HT2 / metabolism*
-
Serotonin / pharmacology
-
Serotonin 5-HT2 Receptor Agonists
-
Serotonin 5-HT2 Receptor Antagonists
-
Serotonin Agents / pharmacology
-
Signal Transduction / drug effects
-
Signal Transduction / physiology*
-
Transfection
Substances
-
Amphetamines
-
Fluorobenzenes
-
Hormones
-
Inositol Phosphates
-
Ionophores
-
Piperidines
-
Receptors, Corticotropin-Releasing Hormone
-
Receptors, Serotonin, 5-HT2
-
Serotonin 5-HT2 Receptor Agonists
-
Serotonin 5-HT2 Receptor Antagonists
-
Serotonin Agents
-
Serotonin
-
CRF Receptor, Type 1
-
Corticotropin-Releasing Hormone
-
Monensin
-
Cyclic AMP
-
volinanserin
-
4-iodo-2,5-dimethoxyphenylisopropylamine